Leukemia risk seen with MS drug mitoxantrone (Reuters)
Reuters – An Italian study confirms that people with multiple sclerosis (MS) who are treated with the drug mitoxantrone have an increased risk of developing acute leukemia. Furthermore, it seems that the risk is significantly higher than previously reported.